Clinical Trial Detail

NCT ID NCT01811368
Title Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma
Recruitment Recruiting
Gender
Phase Phase II
Variant Requirements No
Sponsors University of California, Davis
Indications

CLL/SLL

mantle cell lymphoma

marginal zone B-cell lymphoma

non-Hodgkin lymphoma

Hodgkin's lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

Therapies

anti-thymocyte globulin + Ibritumomab tiuxetan + Rituximab

Cyclosporine + Mycophenolate mofetil

Age Groups: adult senior

No variant requirements are available.